In zebrafish, Moens’ model organism of choice, the pharyngeal arches’ segmented organization is easy to see. In fish, the pharyngeal arches develop into the muscles that control swallowing, as well as another complex task: food sorting.
Fish have taste buds in their throats, not their mouths, and they use their throats to sample food and decide whether to continue swallowing it or to spit it out. They can also use their dexterous throats to remove edible material like algae from stones or other nonfood items before spitting out the stones.
“Fundamentally, we're interested in development of humans and the human nervous system,” Moens said. “Because these cranial nerves are really evolutionarily ancient, we can study their development in the zebrafish and know that we're learning something about fundamental mechanisms underlying nervous system development in humans as well.”
Retinoic acid controls timing
The vagus motor neurons that reach into the pharyngeal arches start out as a cluster in the brain. They don’t all send their long axons racing for the pharyngeal arches at once. Instead, small subgroups of neurons extend their axons at different times: Those closest to the fish’s head start first, then the next group, then the next, ending with those closest to the tail. The pharyngeal arches receive their neurons in the same sequential fashion: The forward-most arch is innervated first, and on down the line as the arches get closer to the fish’s tail.
In this study, Moens and Dr. Adam Isabella, the postdoctoral fellow who spearheaded the work, were hunting for the molecular mechanism controlling this timing. To reveal it, Isabella isolated the neurons innervating different pharyngeal arches at different time points and compared the genes they had turned on. He found that the genes related to retinoic acid signaling were the most different between the neurons that grew early or late during topographic map development.
Derived from vitamin A, retinoic acid plays an important role in patterning major brain areas earlier in development, but the role that Isabella revealed in the vagus motor topographic map was new, Moens said.
Isabella used fluorescent molecules to track the growth of neurons and the presence of retinoic acid. He found that retinoic acid levels changed across the neurons over time. Levels were high in all the neurons before topographic map development. Then, like a tide receding, retinoic acid ebbed across the neurons, starting in the front-most. Neurons didn’t begin growing toward the pharyngeal arches until retinoic acid levels faded. When Isabella blocked retinoic acid from dropping, the neurons couldn’t properly reach the arches.
But how was retinoic acid inhibiting neuron growth? To guide neurons to their targets, the body uses chemoattractants, molecular beacons that help cells navigate to new areas of the body. To be guided, a cell must have the right molecule — known as a receptor — that allows it to sense its beacon.
Moens and Isabella found that retinoic acid prevents neurons from producing their beacon-sensing receptor, called Met. Once retinoic acid levels receded, Met levels went up and neurons were able to begin sending their axons toward the pharyngeal arches.
Moens and Isabella had expected that this timing mechanism only came into play on the neuronal side. It seemed reasonable to assume that sequential release of the neurons would be enough to match them to the proper pharyngeal arch, as each of these also forms sequentially.
Unexpectedly, Isabella found that the molecular beacon drawing the neurons, called Hgf, was also regulated by retinoic acid. It only got turned on to attract the neurons as retinoic acid ebbed.
“At the same time that retinoic acid was releasing expression of Met across the motor neurons, it was also releasing expression of Hgf in the pharyngeal arches so that the matching mechanism could happen in lockstep,” Moens said. “It was more satisfying than surprising to see that you could roll out expression of receptor and ligand in such a regulated way over time to generate a topographic map.”
Presumably, she said, the redundancy is a fail-safe to ensure proper topographic map formation even if the embryo is developing in less-than-ideal conditions.
What purpose does the topographic map serve?
How, exactly, retinoic acid keeps Met and Hgf turned off is one of the narrower questions Moens and her team are now asking. Whether retinoic acid comes from the same source in both areas is another open question.
She’s also thinking bigger. The vagus nerve coordinates several different reflexes in response to different sensory stimuli. It somehow ensures that when we see blood, our heart rate drops to prevent a heart attack, rather than triggering a coughing fit. Does the topographic map make this possible?
“We hypothesize that the topographic map that we have described is set up in order to allow for the matching of sensory information coming in on the vagus nerve and motor information going back out,” Moens said.
She and her team are working to map the topography of the vagus’ sensory component and see how it matches the motor component they’ve already mapped.
“We’re developing behavioral tests to activate the sensory component of the vagus and visualize what the motor responses are and whether they're spatially organized as well,” she said.
They’re also working to understand whether this map can regenerate after damage, which could have important implications for understanding how to repair a dysfunctional vagus nerve, Moens said.
And though at first glance her work may seem a surprising fit in a cancer research center, it’s not out of place, Moens said.
“Even though we are studying neurons [that are no longer dividing], which can be counted on not to turn into tumors, the signaling pathways that we have discovered to control the development of the vagus topographic map are important cancer targets,” she said.
Cancer cells often reactivate early developmental pathways that allow them to grow and move in ways that normal cells can’t. For example, some tumor cells repurpose Met, the receptor that Moens and Isabella discovered that guides motor neurons, to metastasize, or spread, through the body.
“There are even reports that the antagonistic relationship we have discovered between retinoic acid and Met in the context of the zebrafish vagus motor nerve may also be active in tumor cells, suggesting that retinoic acid could work through this pathway (as well as others) to suppress tumor growth and metastasis,” Moens said. “This underlines the value of discovering the cellular and molecular mechanisms underlying normal development.”
The National Institutes of Health and the American Heart Association funded this work.